Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10580)
All Articles published online
|
Publishing Process of This Article
|
Oct 26, 2013 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Garg M. Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer. World J Stem Cells 2013; 5(4): 188-195 [PMID: 24179606 DOI: 10.4252/wjsc.v5.i4.188] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v5/i4/188.htm |
| Number | Citing Articles |
| 1 |
Minal Garg. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer and Metastasis Reviews 2015; 34(4): 691 doi: 10.1007/s10555-015-9589-6
|
| 2 |
Siva K. P. Konduru, Santoshi Muppala. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 179 doi: 10.1007/978-981-13-1486-5_13
|
| 3 |
Eunjeong Kang, Jihye Seo, Haelim Yoon, Sayeon Cho. The Post-Translational Regulation of Epithelial–Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis. International Journal of Molecular Sciences 2021; 22(7): 3591 doi: 10.3390/ijms22073591
|
| 4 |
Jie Min, Chiho Mashimo, Takayuki Nambu, Hugo Maruyama, Hiroki Takigawa, Toshinori Okinaga. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum. Archives of Oral Biology 2024; 160: 105897 doi: 10.1016/j.archoralbio.2024.105897
|
| 5 |
Minal Garg. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Expert Opinion on Therapeutic Targets 2015; 19(2): 285 doi: 10.1517/14728222.2014.975794
|
| 6 |
Rinni Singh, Jamal A. Ansari, Niharika Maurya, Anil Mandhani, Vinita Agrawal, Minal Garg. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder. Clinical Genitourinary Cancer 2017; 15(2): e187 doi: 10.1016/j.clgc.2016.07.021
|
| 7 |
Samatha Bhat, Shama Prasada Kabekkodu, Divya Adiga, Rayzel Fernandes, Vaibhav Shukla, Poonam Bhandari, Deeksha Pandey, Krishna Sharan, Kapaettu Satyamoorthy. ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer. Cell Biology and Toxicology 2021; 37(5): 731 doi: 10.1007/s10565-021-09582-4
|
| 8 |
Daniel Cruceriu, Oana Baldasici, Ovidiu Balacescu, Ioana Berindan-Neagoe. The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches. Cellular Oncology 2020; 43(1): 1 doi: 10.1007/s13402-019-00489-1
|
| 9 |
Masoomeh Yari Kalashgrani, Seyyed Mojtaba Mousavi, Muhammad Hussnain Akmal, Ahmad Gholami, Navid Omidifar, Wei-Hung Chiang, Chin Wei Lai, Md. Ripaj Uddin, Raed H. Althomali, Mohammed M. Rahman. Biosensors for metastatic cancer cell detection. Clinica Chimica Acta 2024; 559: 119685 doi: 10.1016/j.cca.2024.119685
|
| 10 |
Patricia G. Santamaria, Gema Moreno‐Bueno, Francisco Portillo, Amparo Cano. EMT: Present and future in clinical oncology. Molecular Oncology 2017; 11(7): 718 doi: 10.1002/1878-0261.12091
|
| 11 |
Tariq Alqahtani, Abdullah Alswied, Daekyu Sun. Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity. Cancers 2021; 13(13): 3288 doi: 10.3390/cancers13133288
|
| 12 |
Liza J. Burton, Ohuod Hawsawi, Quentin Loyd, Veronica Henderson, Simone Howard, Maxine Harlemon, Camille Ragin, Robin Roberts, Nathan Bowen, Andrew Gacii, Valerie Odero-Marah, Aamir Ahmad. Association of Epithelial Mesenchymal Transition with prostate and breast health disparities. PLOS ONE 2018; 13(9): e0203855 doi: 10.1371/journal.pone.0203855
|
| 13 |
Prabesh Khatiwada, Archana Kannan, Mamata Malla, Megan Dreier, Lirim Shemshedini. Androgen up-regulation of Twist1 gene expression is mediated by ETV1. PeerJ 2020; 8: e8921 doi: 10.7717/peerj.8921
|
| 14 |
Yiwei Li, Asfar S. Azmi, Ramzi M. Mohammad. Deregulated transcription factors and poor clinical outcomes in cancer patients. Seminars in Cancer Biology 2022; 86: 122 doi: 10.1016/j.semcancer.2022.08.001
|
| 15 |
Abdul Q. Khan, Adria Hasan, Snober S. Mir, Khalid Rashid, Shahab Uddin, Martin Steinhoff. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy. Seminars in Cancer Biology 2024; 100: 1 doi: 10.1016/j.semcancer.2024.03.002
|
| 16 |
Keijo Fukushima, Hiromichi Fujino. Identification and Characterization of Human Colorectal Cancer Cluster Predominantly Expressing EP3 Prostanoid Receptor Subtype. Biological and Pharmaceutical Bulletin 2022; 45(6): 698 doi: 10.1248/bpb.b22-00104
|
| 17 |
Ajda Coker-Gurkan, Derya Bulut, Recep Genc, Elif-Damla Arisan, Pınar Obakan-Yerlikaya, Narcin Palavan-Unsal. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells. Molecular Biology Reports 2019; 46(1): 355 doi: 10.1007/s11033-018-4479-y
|
| 18 |
Kiran Tripathi, Minal Garg. Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer. Journal of Cell Communication and Signaling 2018; 12(3): 513 doi: 10.1007/s12079-017-0441-3
|
| 19 |
Ma. Carmela P. Dela Cruz, Paul Mark B. Medina. Epithelial–mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC). Cancer Pathogenesis and Therapy 2024; doi: 10.1016/j.cpt.2024.07.001
|
| 20 |
Shravanti Mukherjee, Shilpi Saha, Argha Manna, Minakshi Mazumdar, Samik Chakraborty, Shrutarshi Paul, Tanya Das. Targeting Cancer Stem Cells by Phytochemicals: a Multimodal Approach to Colorectal Cancer. Current Colorectal Cancer Reports 2014; 10(4): 431 doi: 10.1007/s11888-014-0251-4
|
| 21 |
Nagesh Kishan Panchal, Jerine Peter S, Chandrayee Sil, Pratiksha Chhetri, Evan Prince Sabina. Targeting Epithelial to Mesenchymal Transition in Breast Cancer with Bioactive Compounds derived from Solanum surattense: A GC-MS and Molecular Docking approach. Research Journal of Pharmacy and Technology 2022; : 5637 doi: 10.52711/0974-360X.2022.00951
|
| 22 |
A. N. K. V. Sravani, Natarajan Chandrasekaran. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. 2024; : 1 doi: 10.1007/978-3-030-73317-9_141-1
|
| 23 |
Nataliya Babyshkina, Tatyana Dronova, Daiana Erdyneeva, Polina Gervas, Nadejda Cherdyntseva. Role of TGF-β signaling in the mechanisms of tamoxifen resistance. Cytokine & Growth Factor Reviews 2021; 62: 62 doi: 10.1016/j.cytogfr.2021.09.005
|
| 24 |
Annalisa Pecoraro, Pietro Carotenuto, Giulia Russo, Annapina Russo. Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-51723-7
|
| 25 |
Hoai-Nga Thi Nguyen, Marie Kawahara, Cat-Khanh Vuong, Mizuho Fukushige, Toshiharu Yamashita, Osamu Ohneda. SARS-CoV-2 M Protein Facilitates Malignant Transformation of Breast Cancer Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.923467
|
| 26 |
Ameen A. Mohammed, Fabio Rotondo, David G. Munoz, Kalman Kovacs, Juan M. Bilbao, Jason R. Karamchandani, Antonio Di Ieva, Michael D. Cusimano. Diagnostic and prognostic biomarkers of a sellar melanocytic tumor mimicking pituitary adenoma: Case report and literature review. Pathology - Research and Practice 2015; 211(9): 682 doi: 10.1016/j.prp.2015.04.005
|
| 27 |
Md. Khurshidul Hassan, Dinesh Kumar, Saket Awadhesbhai Patel, Manjusha Dixit. EEF1A2 triggers stronger ERK mediated metastatic program in ER negative breast cancer cells than in ER positive cells. Life Sciences 2020; 262: 118553 doi: 10.1016/j.lfs.2020.118553
|
| 28 |
Xiaoran Ma, Jibiao Wu, Bin Wang, Cun Liu, Lijuan Liu, Changgang Sun. Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review). International Journal of Oncology 2022; 61(5) doi: 10.3892/ijo.2022.5424
|
| 29 |
Busra Buyuk, Sha Jin, Kaiming Ye. Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis. Cellular and Molecular Bioengineering 2022; 15(1): 1 doi: 10.1007/s12195-021-00694-9
|
| 30 |
Barnali Deb, Prashant Kumar. Tumor Heterogeneity and Phenotypic Plasticity in Bladder Carcinoma. Journal of the Indian Institute of Science 2020; 100(3): 567 doi: 10.1007/s41745-020-00183-4
|
| 31 |
Unbin Chae, Bokyung Kim, HanSeop Kim, Young-Ho Park, Seung Hwan Lee, Sun-Uk Kim, Dong-Seok Lee. Peroxiredoxin-6 regulates p38-mediated epithelial–mesenchymal transition in HCT116 colon cancer cells. Journal of Biological Research-Thessaloniki 2021; 28(1) doi: 10.1186/s40709-021-00153-6
|
| 32 |
Rashidah Baharudin, Francis Yew Fu Tieng, Learn-Han Lee, Nurul Syakima Ab Mutalib. Epigenetics of SFRP1: The Dual Roles in Human Cancers. Cancers 2020; 12(2): 445 doi: 10.3390/cancers12020445
|
| 33 |
Hye Min Kim, Haeryoung Kim, Young Nyun Park. Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report. Clinical and Molecular Hepatology 2015; 21(3): 309 doi: 10.3350/cmh.2015.21.3.309
|
| 34 |
Siming Xie, Zhiyuan Lu, Yanzhu Lin, Lijia Shen, Cao Yin. Upregulation of PTEN suppresses invasion in Tca8113 tongue cancer cells through repression of epithelial–mesenchymal transition (EMT). Tumor Biology 2016; 37(5): 6681 doi: 10.1007/s13277-015-4486-8
|
| 35 |
Prabhu Arumugam, Satyajit Bhattacharya, Joanne Chin-Aleong, Melania Capaso, Hemant M. Kocher. Expression of polymeric immunoglobulin receptor and stromal activity in pancreatic ductal adenocarcinoma. Pancreatology 2017; 17(2): 295 doi: 10.1016/j.pan.2017.01.013
|
| 36 |
Nivedita Bhardwaj, Bharat Goel, Nancy Tripathi, Bharat Sahu, Shreyans K. Jain. A comprehensive review on chemistry and pharmacology of marine bioactives as antimetastatic agents. European Journal of Medicinal Chemistry Reports 2022; 4: 100023 doi: 10.1016/j.ejmcr.2021.100023
|
| 37 |
ELŻBIETA PŁUCIENNIK, MAGDALENA NOWAKOWSKA, KAROLINA POSPIECH, ANNA STĘPIEŃ, MATEUSZ WOŁKOWICZ, MAŁGORZATA GAŁDYSZYŃSKA, MARTA POPĘDA, KATARZYNA WÓJCIK-KROWIRANDA, ANDRZEJ BIEŃKIEWICZ, ANDRZEJ K. BEDNAREK. The role of WWOX tumor suppressor gene in the regulation of EMT process via regulation of CDH1-ZEB1-VIM expression in endometrial cancer. International Journal of Oncology 2015; 46(6): 2639 doi: 10.3892/ijo.2015.2964
|
| 38 |
Ye-Seul Kim, Bo-Rim Yi, Nam-Hyung Kim, Kyung-Chul Choi. Role of the epithelial–mesenchymal transition and its effects on embryonic stem cells. Experimental & Molecular Medicine 2014; 46(8): e108 doi: 10.1038/emm.2014.44
|
| 39 |
Kumari Sonal Choudhary, Neha Rohatgi, Skarphedinn Halldorsson, Eirikur Briem, Thorarinn Gudjonsson, Steinn Gudmundsson, Ottar Rolfsson, Jeffrey J. Saucerman. EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT. PLOS Computational Biology 2016; 12(6): e1004924 doi: 10.1371/journal.pcbi.1004924
|
| 40 |
Jingxin Zhang, Enting Lu, Lei Deng, Yaoxuan Zhu, Xiaoqing Lu, Xinyuan Li, Fangmei Li, Yan Yan, Jing-Yan Han, Yin Li, Yi Zhang. Immunological roles for resistin and related adipokines in obesity-associated tumors. International Immunopharmacology 2024; 142: 112911 doi: 10.1016/j.intimp.2024.112911
|
| 41 |
Mau Ern Poh, Chong Kin Liam, Kein Seong Mun, Chee Shee Chai, Chee Kuan Wong, Jiunn Liang Tan, Thian Chee Loh, Ka Kiat Chin. Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy. Thoracic Cancer 2019; 10(9): 1841 doi: 10.1111/1759-7714.13156
|
| 42 |
Frederic St-Denis-Bissonnette, Rachil Khoury, Karan Mediratta, Sara El-Sahli, Lisheng Wang, Jessie R. Lavoie. Applications of Extracellular Vesicles in Triple-Negative Breast Cancer. Cancers 2022; 14(2): 451 doi: 10.3390/cancers14020451
|
| 43 |
Iryna Horak, Svitlana Prylutska, Iryna Krysiuk, Serhii Luhovskyi, Oleksii Hrabovsky, Nina Tverdokhleb, Daria Franskevych, Dmytro Rumiantsev, Anton Senenko, Maxim Evstigneev, Liudmyla Drobot, Olga Matyshevska, Uwe Ritter, Jacek Piosik, Yuriy Prylutskyy. Nanocomplex of Berberine with C60 Fullerene Is a Potent Suppressor of Lewis Lung Carcinoma Cells Invasion In Vitro and Metastatic Activity In Vivo. Materials 2021; 14(20): 6114 doi: 10.3390/ma14206114
|
| 44 |
Wilson Wong, Anandwardhan A. Hardikar, Mugdha V. Joglekar. Pancreatic Islet Biology. Stem Cell Biology and Regenerative Medicine 2016; : 217 doi: 10.1007/978-3-319-45307-1_9
|
| 45 |
Mingjun Zhang, Michael Haughey, Nai-Yu Wang, Kate Blease, Ann M. Kapoun, Suzana Couto, Igor Belka, Timothy Hoey, Matthew Groza, James Hartke, Brydon Bennett, Jennifer Cain, Austin Gurney, Brent Benish, Paola Castiglioni, Clifton Drew, Jean Lachowicz, Leon Carayannopoulos, Steven D. Nathan, Jorg Distler, David A. Brenner, Kandasamy Hariharan, Ho Cho, Weilin Xie, Partha Mukhopadhyay. Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. PLOS ONE 2020; 15(3): e0229445 doi: 10.1371/journal.pone.0229445
|
| 46 |
Xiaoqin Zhang, Linda Xiaoyan Li, Chen Yu, Karl A. Nath, Shougang Zhuang, Xiaogang Li. Targeting lysine‐specific demethylase 1A inhibits renal epithelial–mesenchymal transition and attenuates renal fibrosis. The FASEB Journal 2022; 36(1) doi: 10.1096/fj.202101566R
|
| 47 |
Jonathan Sherman, Adam Bobak, Tasneem Arsiwala, Paul Lockman, Sonikpreet Aulakh. Targeting drug resistance in glioblastoma (Review). International Journal of Oncology 2024; 65(2) doi: 10.3892/ijo.2024.5668
|
| 48 |
Jingjing Sha, Yunpeng Bai, Huy Xuan Ngo, Tatsuo Okui, Takahiro Kanno. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition. Biomolecules 2021; 11(6): 893 doi: 10.3390/biom11060893
|
| 49 |
R. Singh, A. Mandhani, V. Agrawal, Minal Garg. Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients. Cancer Microenvironment 2018; 11(1): 23 doi: 10.1007/s12307-017-0199-4
|
| 50 |
Cheng-Hsien Chen, Chung-Yi Cheng, Yen-Cheng Chen, Yuh-Mou Sue, Chung-Te Liu, Tzu-Hurng Cheng, Yung-Ho Hsu, Tso-Hsiao Chen, Weiqing Han. MicroRNA-328 Inhibits Renal Tubular Cell Epithelial-to-Mesenchymal Transition by Targeting the CD44 in Pressure-Induced Renal Fibrosis. PLoS ONE 2014; 9(6): e99802 doi: 10.1371/journal.pone.0099802
|
| 51 |
Gracjana Krzysiek‐Maczka, Tomasz Wrobel, Aneta Targosz, Urszula Szczyrk, Malgorzata Strzalka, Agata Ptak‐Belowska, Jaroslaw Czyz, Tomasz Brzozowski. Helicobacter pylori‐activated gastric fibroblasts induce epithelial‐mesenchymal transition of gastric epithelial cells in vitro in a TGF‐β‐dependent manner. Helicobacter 2019; 24(5) doi: 10.1111/hel.12653
|
| 52 |
Divya Adiga, Raghu Radhakrishnan, Sanjiban Chakrabarty, Prashant Kumar, Shama Prasada Kabekkodu. The Role of Calcium Signaling in Regulation of Epithelial-Mesenchymal Transition. Cells Tissues Organs 2022; 211(2): 134 doi: 10.1159/000512277
|
| 53 |
I-Ting Tsai, Ching-Chuan Kuo, Jing-Ping Liou, Jang-Yang Chang. Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0432-6
|
| 54 |
Sarabjeet Kour Sudan, Sachin Kumar Deshmukh, Teja Poosarla, Nicolette Paolaungthong Holliday, Donna Lynn Dyess, Ajay Pratap Singh, Seema Singh. Resistin: An inflammatory cytokine with multi-faceted roles in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188419 doi: 10.1016/j.bbcan.2020.188419
|
| 55 |
SHIN YOUNG PARK, JUN SANG BAE, EUN JUNG CHA, HYUN HEE CHU, JANG SIHN SOHN, WOO SUNG MOON. Nuclear EpICD expression and its role in hepatocellular carcinoma. Oncology Reports 2016; 36(1): 197 doi: 10.3892/or.2016.4789
|
| 56 |
A.H. Nwabo Kamdje, L. Vecchio, P. Takam Kamga, P.F. Seke Etet, J.M. Muller, G. Bassi, M. Krampera. Introduction to Cancer Metastasis. 2017; : 337 doi: 10.1016/B978-0-12-804003-4.00018-9
|
| 57 |
Tangming Guan, Xiao Yang, Hui Liang, Jiayi Chen, Yan Chen, Yingjie Zhu, Tongzheng Liu. Deubiquitinating enzyme USP9X regulates metastasis and chemoresistance in triple‐negative breast cancer by stabilizing Snail1. Journal of Cellular Physiology 2022; 237(7): 2992 doi: 10.1002/jcp.30763
|
| 58 |
Sourik S. Ganguly, Xiaohong Li, Cindy K. Miranti. The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis. Frontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00364
|
| 59 |
Olena Bilyk, Mackenzie Coatham, Michael Jewer, Lynne-Marie Postovit. Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology. Frontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00145
|
| 60 |
Ashleigh Pulkoski-Gross, Xi E. Zheng, Deborah Kim, Jillian Cathcart, Jian Cao. Intestinal Tumorigenesis. 2015; : 309 doi: 10.1007/978-3-319-19986-3_11
|
| 61 |
Alena Liskova, Lenka Koklesova, Marek Samec, Karel Smejkal, Samson Mathews Samuel, Elizabeth Varghese, Mariam Abotaleb, Kamil Biringer, Erik Kudela, Jan Danko, Mehdi Shakibaei, Taeg Kyu Kwon, Dietrich Büsselberg, Peter Kubatka. Flavonoids in Cancer Metastasis. Cancers 2020; 12(6): 1498 doi: 10.3390/cancers12061498
|
| 62 |
Christopher Montemagno, Gilles Pagès. Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00584
|
| 63 |
Heng‐Chung Kung, Jun Yu. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study. MedComm 2023; 4(2) doi: 10.1002/mco2.216
|
| 64 |
Samantha Gogola, Michael Rejzer, Hisham F. Bahmad, Wassim Abou-Kheir, Yumna Omarzai, Robert Poppiti. Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside. Cancers 2023; 15(8): 2309 doi: 10.3390/cancers15082309
|
| 65 |
Mina Homayoonfal, Zatollah Asemi, Bahman Yousefi. Targeting microRNAs with thymoquinone: a new approach for cancer therapy. Cellular & Molecular Biology Letters 2021; 26(1) doi: 10.1186/s11658-021-00286-5
|
| 66 |
Anja Pišlar, Anahid Jewett, Janko Kos. Cysteine cathepsins: Their biological and molecular significance in cancer stem cells. Seminars in Cancer Biology 2018; 53: 168 doi: 10.1016/j.semcancer.2018.07.010
|
| 67 |
Sreemanti Das, Pritha Mukherjee, Ranodeep Chatterjee, Zarqua Jamal, Urmi Chatterji. Enhancing Chemosensitivity of Breast Cancer Stem Cells by Downregulating SOX2 and ABCG2 Using Wedelolactone-encapsulated Nanoparticles. Molecular Cancer Therapeutics 2019; 18(3): 680 doi: 10.1158/1535-7163.MCT-18-0409
|
| 68 |
Maja Sabol, Jean Calleja-Agius, Riccardo Di Fiore, Sherif Suleiman, Sureyya Ozcan, Mark P. Ward, Petar Ozretić. (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers. Cancers 2021; 13(20): 5040 doi: 10.3390/cancers13205040
|
| 69 |
Myung-Jin Kim, Jihyun Lim, Young Yang, Myeong-Sok Lee, Jong-Seok Lim. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial–mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling. Cancer Letters 2014; 354(1): 33 doi: 10.1016/j.canlet.2014.06.023
|
| 70 |
Mohammad Hossein Musavi Shenas, Shadi Eghbal‐Fard, Vahid Mehrisofiani, Nima Abd Yazdani, Omid Rahbar Farzam, Faroogh Marofi, Mehdi Yousefi. MicroRNAs and signaling networks involved in epithelial–mesenchymal transition. Journal of Cellular Physiology 2019; 234(5): 5775 doi: 10.1002/jcp.27489
|
| 71 |
Rathna Silviya Lodi, Bin Yu, Lin Xia, Fang Liu. Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment. Human Immunology 2021; 82(12): 937 doi: 10.1016/j.humimm.2021.06.007
|
| 72 |
Karen Yamaguchi, Tomofumi Yamamoto, Junichiro Chikuda, Tatsuo Shirota, Yusuke Yamamoto. Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer. Biomolecules 2022; 12(2): 284 doi: 10.3390/biom12020284
|
| 73 |
Nobendu Mukerjee, Swastika Maitra, Sukhamoy Gorai, Arabinda Ghosh, Athanasiosis Alexiou, Nanasaheb D. Thorat. Revolutionizing Human papillomavirus (HPV)‐related cancer therapies: Unveiling the promise of Proteolysis Targeting Chimeras (PROTACs) and Proteolysis Targeting Antibodies (PROTABs) in cancer nano‐vaccines. Journal of Medical Virology 2023; 95(10) doi: 10.1002/jmv.29135
|
| 74 |
Ioanna Akrida, Maria Makrygianni, Sofia Nikou, Francesk Mulita, Vasiliki Bravou, Helen Papadaki. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors. Pathology - Research and Practice 2024; 262: 155551 doi: 10.1016/j.prp.2024.155551
|
| 75 |
Zhihong Cai, Yijing Cao, Yichen Luo, Haobin Hu, Hui Ling. Signalling mechanism(s) of epithelial–mesenchymal transition and cancer stem cells in tumour therapeutic resistance. Clinica Chimica Acta 2018; 483: 156 doi: 10.1016/j.cca.2018.04.033
|
| 76 |
Justyna Mikuła-Pietrasik, Paweł Uruski, Andrzej Tykarski, Krzysztof Książek. The peritoneal “soil” for a cancerous “seed”: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cellular and Molecular Life Sciences 2018; 75(3): 509 doi: 10.1007/s00018-017-2663-1
|
| 77 |
Benoît Ranchoux, Virginie F. Tanguay, Frédéric Perros. Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension. 2020; : 63 doi: 10.1007/978-981-15-1185-1_6
|
| 78 |
Jiang Li, Qian Wei, Ke Song, Youxin Wang, Yuxin Yang, Miao Li, Jiaying Yu, Guangxu Su, Luyuan Peng, Bendong Fu, Pengfei Yi. Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1247800
|
| 79 |
R. Singh, U. P. Singh, V. Agrawal, M. Garg. Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients. Molecular Biology Reports 2022; 49(8): 7541 doi: 10.1007/s11033-022-07563-2
|
| 80 |
Yun-Jeong Jeong, Soon-Kyung Hwang, Mi-Hee Yu, Yuna Cho, Kwon-Ho Song, Junji Magae, Eon Ju Jeon, Young-Chae Chang. 4-O-methylascochlorin-stimulated HIF-1α expression induces the epithelial mesenchymal transition and cell survival in breast cancer cells. Toxicology in Vitro 2022; 81: 105342 doi: 10.1016/j.tiv.2022.105342
|
| 81 |
Yu-Cheng Lee, Cheng-Han Lin, Wei-Lun Chang, Wen-Der Lin, Jhih-Kai Pan, Wei-Jan Wang, Bor-Chyuan Su, Hsien-Hui Chung, Chen-Hsun Tsai, Forn-Chia Lin, Wen-Ching Wang, Pei-Jung Lu. Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences 2022; 23(8): 4367 doi: 10.3390/ijms23084367
|
| 82 |
Elisabete F Carapuça, Emilios Gemenetzidis, Christine Feig, Tashinga E Bapiro, Michael D Williams, Abigail S Wilson, Francesca R Delvecchio, Prabhu Arumugam, Richard P Grose, Nicholas R Lemoine, Frances M Richards, Hemant M Kocher. Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma. The Journal of Pathology 2016; 239(3): 286 doi: 10.1002/path.4727
|
| 83 |
Emily N. Arner, Wenting Du, Rolf A. Brekken. Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01049
|
| 84 |
Xiu Hu, Wei Chen. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma. World Journal of Clinical Cases 2021; 9(19): 4998-5006 doi: 10.12998/wjcc.v9.i19.4998
|
| 85 |
Dennis Pedri, Panagiotis Karras, Ewout Landeloos, Jean‐Christophe Marine, Florian Rambow. Epithelial‐to‐mesenchymal‐like transition events in melanoma. The FEBS Journal 2022; 289(5): 1352 doi: 10.1111/febs.16021
|
| 86 |
Li‐Yuan Bai, Kay Li‐Hui Wu, Chang‐Fang Chiu, Hong‐Chu Chao, Wei‐Yu Lin, Jing‐Lan Hu, Bo‐Rong Peng, Jing‐Ru Weng. Extract of Ficus septica modulates apoptosis and migration in human oral squamous cell carcinoma cells. Environmental Toxicology 2023; 38(3): 666 doi: 10.1002/tox.23716
|
| 87 |
Anitha K. Shenoy, Jianrong Lu. Cancer cells remodel themselves and vasculature to overcome the endothelial barrier. Cancer Letters 2016; 380(2): 534 doi: 10.1016/j.canlet.2014.10.031
|
| 88 |
Melati Putri Pertiwi, Dwi Listyorini, Hendra Susanto, Adeodatus Yuda Handaya. MTA3 gene expression as potential gene biomarker for epithelial mesenchymal transition (EMT) study in colorectal cancer (CRC) cases. THE 6TH INTERNATIONAL CONFERENCE ON BIOLOGICAL SCIENCE ICBS 2019: “Biodiversity as a Cornerstone for Embracing Future Humanity” 2020; 2260: 040002 doi: 10.1063/5.0016464
|
| 89 |
Sarada Achyutuni, Revathy Nadhan, Satheesh Kumar Sengodan, Priya Srinivas. The prodigious network of chromosome 17 miRNAs regulating cancer genes that influence the hallmarks of cancer. Seminars in Oncology 2017; 44(4): 254 doi: 10.1053/j.seminoncol.2017.11.001
|
| 90 |
Rebar N. Mohammed, Mohsen Khosravi, Heshu Sulaiman Rahman, Ali Adili, Navid Kamali, Pavel Petrovich Soloshenkov, Lakshmi Thangavelu, Hossein Saeedi, Navid Shomali, Rozita Tamjidifar, Alireza Isazadeh, Ramin Aslaminabad, Morteza Akbari. Anastasis: cell recovery mechanisms and potential role in cancer. Cell Communication and Signaling 2022; 20(1) doi: 10.1186/s12964-022-00880-w
|
| 91 |
Xuetao Sun, Blessing Nkennor, Olya Mastikhina, Kayla Soon, Sara S. Nunes. Endothelium-mediated contributions to fibrosis. Seminars in Cell & Developmental Biology 2020; 101: 78 doi: 10.1016/j.semcdb.2019.10.015
|
| 92 |
Chun-Wen Su, Yu-Chao Chang, Ming-Hsien Chien, Yi-Hsien Hsieh, Mu-Kuan Chen, Chiao-Wen Lin, Shun-Fa Yang. Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis. Cell Death & Disease 2019; 10(11) doi: 10.1038/s41419-019-2016-0
|
| 93 |
Xiaoyu Yang, Xue Bi, Fang Liu, Jiafei Huang, Zhongguo Zhang. Predictive Efficacy of Circulating Tumor Cells in First Drainage Vein Blood from Patients with Colorectal Cancer Liver Metastasis. Cancer Investigation 2022; 40(9): 767 doi: 10.1080/07357907.2022.2098970
|
| 94 |
Tzu-Ming Jao, Woei-Horng Fang, Shih-Ci Ciou, Sung-Liang Yu, Yu-Lin Hung, Wei-Ting Weng, Tsai-Yi Lin, Ming-Hong Tsai, Ya-Chien Yang. PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer. Cancer Letters 2021; 499: 290 doi: 10.1016/j.canlet.2020.11.017
|
| 95 |
Dan Yang, Xin Cao, Fan Wang, Haijing Jiang, Dingding Feng, Hao Guo, Lei Du, Yingliang Jin, Yansu Chen, Xiaoxing Yin, Chenglin Li. LFG-500, a novel synthetic flavonoid, suppresses epithelial–mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment. Cancer Letters 2017; 400: 137 doi: 10.1016/j.canlet.2017.04.035
|
| 96 |
Harinarayanan Janakiraman, Reniqua P. House, Vamsi K. Gangaraju, J. Alan Diehl, Philip H. Howe, Viswanathan Palanisamy. The Long (lncRNA) and Short (miRNA) of It: TGFβ-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Molecular Cancer Research 2018; 16(4): 567 doi: 10.1158/1541-7786.MCR-17-0547
|
| 97 |
Young-Sun Lee, Osung Kwon, Geuk-Rae Jeong, Junyeol Noh, Sung Eun Kim, Gwan-Su Yi, Eun Mi Hwang, Jae-Yong Park. Deficiency of TTYH1 Expression Reduces the Migration and Invasion of U2OS Human Osteosarcoma Cells. Life 2022; 12(4): 530 doi: 10.3390/life12040530
|
| 98 |
Anneliese Vélez-Pérez, Richard S. P. Huang, Jamie M. Everett, Shan Guo, Jamie Buryanek, Ron J. Karni, Robert E. Brown. Carcinosarcoma of the Parotid. International Journal of Surgical Pathology 2015; 23(2): 116 doi: 10.1177/1066896914562278
|
| 99 |
R. Singh, A. Mandhani, V. Agrawal, M. Garg. Immunohistochemical Studies to Examine the Diagnostic and Prognostic Implications of Epithelial-to-Mesenchymal Transition in Patients with Urothelial Carcinoma of the Bladder. SN Comprehensive Clinical Medicine 2019; 1(4): 277 doi: 10.1007/s42399-018-0028-1
|
| 100 |
Tao Wan, Tianwei Zhang, Xiaoying Si, Yanming Zhou. Overexpression of EMT-inducing transcription factors as a potential poor prognostic factor for hepatocellular carcinoma in Asian populations: A meta-analysis. Oncotarget 2017; 8(35): 59500 doi: 10.18632/oncotarget.18352
|
| 101 |
Amy Oh, Makayla Pardo, Anaelena Rodriguez, Connie Yu, Lisa Nguyen, Olin Liang, Anna Chorzalska, Patrycja M. Dubielecka. NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01207-z
|
| 102 |
Yanhui Ma, Xiaolei Zhang, Xiaoxuan Xu, Liang Shen, Yao Yao, Ziyan Yang, Peishu Liu, Valentin Ceña. STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells. PLOS ONE 2015; 10(4): e0124924 doi: 10.1371/journal.pone.0124924
|
| 103 |
Megan Mladinich, Diane Ruan, Chia-Hsin Chan, Robert Gourdie. Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/5285892
|
| 104 |
Gustavo Untiveros, Lindsay Dezi, Megan Gillette, Julia Sidor, Luigi Strizzi. Normal Skin Cells Increase Aggressiveness of Cutaneous Melanoma by Promoting Epithelial-to-Mesenchymal Transition via Nodal and Wnt Activity. International Journal of Molecular Sciences 2021; 22(21): 11719 doi: 10.3390/ijms222111719
|
| 105 |
Małgorzata Chmielewska-Kassassir, Katarzyna Sobierajska, Wojciech M. Ciszewski, Jakub Kryczka, Andrzej Zieleniak, Lucyna A. Wozniak. Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma. Cancers 2023; 15(20): 5003 doi: 10.3390/cancers15205003
|
| 106 |
Yujiao Tang, Yon-Suk Kim, Eun-Ju Choi, Young Joung Hwang, Yeong Sik Yun, Sung Mun Bae, Pyo-Jam Park, Eun-Kyung Kim. Taurine 10. Advances in Experimental Medicine and Biology 2017; 975: 1203 doi: 10.1007/978-94-024-1079-2_96
|
| 107 |
Deepika Neelakantan, David J Drasin, Heide L Ford. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis. Cell Adhesion & Migration 2015; 9(4): 265 doi: 10.4161/19336918.2014.972761
|
| 108 |
Tetsuo Yokota, Hiroyuki Nojima, Satoshi Kuboki, Hideyuki Yoshitomi, Katsunori Furukawa, Tsukasa Takayashiki, Shigetsugu Takano, Masayuki Ohtsuka. Sphingosine-1-phosphate Receptor-1 Promotes Vascular Invasion and EMT in Hepatocellular Carcinoma. Journal of Surgical Research 2021; 259: 200 doi: 10.1016/j.jss.2020.11.044
|
| 109 |
Yunpeng Bai, Jingjing Sha, Tatsuo Okui, Ichiro Moriyama, Huy Xuan Ngo, Hiroto Tatsumi, Takahiro Kanno. The Epithelial–Mesenchymal Transition Influences the Resistance of Oral Squamous Cell Carcinoma to Monoclonal Antibodies via Its Effect on Energy Homeostasis and the Tumor Microenvironment. Cancers 2021; 13(23): 5905 doi: 10.3390/cancers13235905
|
| 110 |
Qihui Zhou, Ziyong Wu, Xi Cheng, Zhigang Zuo, Cunyu Fan. Exploring Melezitose as a Potential Therapeutic Agent in Lung Cancer: Inhibitory Effects on Cell Proliferation and EMT-Mediated Signaling in A549 Cells. Pharmacognosy Magazine 2024; 20(4): 1286 doi: 10.1177/09731296241251545
|
| 111 |
Yahima Frión-Herrera, Daniela Gabbia, Michela Scaffidi, Letizia Zagni, Osmany Cuesta-Rubio, Sara De Martin, Maria Carrara. The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells. International Journal of Molecular Sciences 2020; 21(5): 1827 doi: 10.3390/ijms21051827
|
| 112 |
Weige Tan, Bodu Liu, Shaohua Qu, Gehao Liang, Wei Luo, Chang Gong. MicroRNAs and cancer: Key paradigms in molecular therapy (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7638
|
| 113 |
Agata Mlynska, Egle Povilaityte, Inga Zemleckaite, Karolina Zilionyte, Marius Strioga, Jan Krasko, Neringa Dobrovolskiene, Mei‐Wen Peng, Birute Intaite, Vita Pasukoniene. Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2‐type macrophage polarization. American Journal of Reproductive Immunology 2018; 80(3) doi: 10.1111/aji.12996
|
| 114 |
Christina K. Cajigas-Du Ross, Shannalee R. Martinez, Leanne Woods-Burnham, Alfonso M. Durán, Sourav Roy, Anamika Basu, Joshua A. Ramirez, Greisha L. Ortiz-Hernández, Leslimar Ríos-Colón, Evgeny Chirshev, Evelyn S. Sanchez-Hernandez, Ubaldo Soto, Celine Greco, Claude Boucheix, Xin Chen, Juli Unternaehrer, Charles Wang, Carlos A. Casiano. RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget 2018; 9(54): 30363 doi: 10.18632/oncotarget.25744
|
| 115 |
Burcu Sengez, Brian I. Carr, Hani Alotaibi. EMT and Inflammation: Crossroads in HCC. Journal of Gastrointestinal Cancer 2023; 54(1): 204 doi: 10.1007/s12029-021-00801-z
|
| 116 |
A. N. K. V. Sravani, Natarajan Chandrasekaran. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. 2024; : 1117 doi: 10.1007/978-3-031-35529-5_141
|
| 117 |
Apostolos Zaravinos. The Regulatory Role of MicroRNAs in EMT and Cancer. Journal of Oncology 2015; 2015: 1 doi: 10.1155/2015/865816
|
| 118 |
Anja Pišlar, Milica Perišić Nanut, Janko Kos. Lysosomal cysteine peptidases – Molecules signaling tumor cell death and survival. Seminars in Cancer Biology 2015; 35: 168 doi: 10.1016/j.semcancer.2015.08.001
|
| 119 |
Daisy Y. Shu, Magdalena Wojciechowski, Frank J. Lovicu. ERK1/2-mediated EGFR-signaling is required for TGFβ-induced lens epithelial-mesenchymal transition. Experimental Eye Research 2019; 178: 108 doi: 10.1016/j.exer.2018.09.021
|
| 120 |
Huimin Liu, Lele Ma, Junzhi Lin, Bo Cao, Duan Qu, Chuanhong Luo, Wei Huang, Li Han, Hong Xu, Zhenfeng Wu, Runchun Xu, Dingkun Zhang. Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer. Pharmacological Research 2020; 155: 104738 doi: 10.1016/j.phrs.2020.104738
|
| 121 |
Swadesh K. Das, Devanand Sarkar, Luni Emdad, Paul B. Fisher. . Advances in Cancer Research 2019; 144: 137 doi: 10.1016/bs.acr.2019.03.011
|
| 122 |
Chao Yang, Limor Rubin, Xiyong Yu, Philip Lazarovici, Wenhua Zheng. Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases. Medicinal Research Reviews 2024; 44(3): 1326 doi: 10.1002/med.22014
|
| 123 |
Yueh-Shan Weng, I-Tsang Chiang, Jai-Jen Tsai, Yu-Chang Liu, Fei-Ting Hsu. Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial–Mesenchymal Transition and Metastasis. International Journal of Radiation Oncology*Biology*Physics 2023; 115(3): 719 doi: 10.1016/j.ijrobp.2022.09.060
|
| 124 |
Anusha Sathyanarayanan, Karthik Subramanian Chandrasekaran, Devarajan Karunagaran. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Cellular Oncology 2017; 40(2): 119 doi: 10.1007/s13402-016-0307-3
|
| 125 |
Souneek Chakraborty, Khalid Bashir Mir, Nathan D. Seligson, Debasis Nayak, Rakesh Kumar, Anindya Goswami. Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis. Cancer and Metastasis Reviews 2020; 39(2): 553 doi: 10.1007/s10555-020-09866-x
|
| 126 |
Cheng-lin Li, Juan Li, Shu-yuan Gong, Meng Huang, Rui Li, Gui-xiang Xiong, Fan Wang, Qiu-ming Zou, Qi Qi, Xiao-xing Yin. Targeting the ILK/YAP axis by LFG-500 blocks epithelial–mesenchymal transition and metastasis. Acta Pharmacologica Sinica 2021; 42(11): 1847 doi: 10.1038/s41401-021-00655-y
|
| 127 |
Olga Fedorova, Sergey Parfenyev, Alexandra Daks, Oleg Shuvalov, Nickolai A. Barlev. The Role of PTEN in Epithelial–Mesenchymal Transition. Cancers 2022; 14(15): 3786 doi: 10.3390/cancers14153786
|
| 128 |
Aeyung Kim, Jin Yeul Ma. Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4479
|
| 129 |
Sina Rahimi, Amaneh Mohammadi Roushandeh, Ebrahim Ahmadzadeh, Ali Jahanian-Najafabadi, Mehryar Habibi Roudkenar. Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types. Molecular Biology Reports 2020; 47(3): 2327 doi: 10.1007/s11033-020-05261-5
|
| 130 |
Javad Ghassemi‑rad, Wasundara Fernando, David Hoskin. Piperlongumine‑loaded nanoparticles inhibit the growth, migration and invasion and epithelial‑to‑mesenchymal transition of triple‑negative breast cancer cells. International Journal of Functional Nutrition 2020; 2(1): 1 doi: 10.3892/ijfn.2020.11
|
| 131 |
Heba Z. Sailem, Chris Bakal. Identification of clinically predictive metagenes that encode components of a network coupling cell shape to transcription by image-omics. Genome Research 2017; 27(2): 196 doi: 10.1101/gr.202028.115
|
| 132 |
Ganesan Arunkumar, Arunagiri Deva Magendhra Rao, Mayakannan Manikandan, Harikrishnan Prasanna Srinivasa Rao, Shanmugam Subbiah, Ramachandran Ilangovan, Avaniyapuram Murugan, Arasambattu Munirajan. Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7296
|
| 133 |
T. A. Gureeva, O. S. Timoshenko, E. V. Kugaevskaya, N. I. Solovyova. Cysteine Cathepsins: Structure, Physiological Functions, and the Role in Carcinogenesis. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2022; 16(2): 91 doi: 10.1134/S1990750822020056
|
| 134 |
Sugandha Bhatia, James Monkman, Alan Kie Leong Toh, Shivashankar H. Nagaraj, Erik W. Thompson. Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring. Biochemical Journal 2017; 474(19): 3269 doi: 10.1042/BCJ20160782
|
| 135 |
Pınar Ö. Eser, Pasi A. Jänne. TGFβ pathway inhibition in the treatment of non-small cell lung cancer. Pharmacology & Therapeutics 2018; 184: 112 doi: 10.1016/j.pharmthera.2017.11.004
|
| 136 |
Yu-Wei Chang, Kamaleshwar P. Singh. Arsenic-Induced Neoplastic Transformation Involves Epithelial–Mesenchymal Transition and Activation of the β-Catenin/c-Myc Pathway in Human Kidney Epithelial Cells. Chemical Research in Toxicology 2019; 32(6): 1299 doi: 10.1021/acs.chemrestox.9b00089
|
| 137 |
Natalia Tołoczko-Iwaniuk, Dorota Dziemiańczyk-Pakieła, Beata Klaudia Nowaszewska, Katarzyna Celińska-Janowicz, Wojciech Miltyk. Celecoxib in Cancer Therapy and Prevention – Review. Current Drug Targets 2019; 20(3): 302 doi: 10.2174/1389450119666180803121737
|
| 138 |
Gracjana Krzysiek‐Maczka, Aneta Targosz, Urszula Szczyrk, Malgorzata Strzałka, Zbigniew Sliwowski, Tomasz Brzozowski, Jarosław Czyz, Agata Ptak‐Belowska. Role of Helicobacter pylori infection in cancer‐associated fibroblast‐induced epithelial‐mesenchymal transition in vitro. Helicobacter 2018; 23(6) doi: 10.1111/hel.12538
|
| 139 |
Siri Amanda Tvingsholm, Ditte Marie Brix, Tuula Kallunki. Molecular and Transcriptional Signatures for ErbB2-Induced Invasion. Current Pharmacology Reports 2019; 5(1): 43 doi: 10.1007/s40495-018-0146-1
|
| 140 |
Minal Garg. Epithelial plasticity in urothelial carcinoma: Current advancements and future challenges. World Journal of Stem Cells 2016; 8(8): 260-267 doi: 10.4252/wjsc.v8.i8.260
|
| 141 |
T.A. Gureeva, O.S. Timoshenko, E.V. Kugaevskaya, N.I. Solovyova. Cysteine cathepsins: structure, physiological functions and their role in carcinogenesis. Biomeditsinskaya Khimiya 2021; 67(6): 453 doi: 10.18097/pbmc20216706453
|
| 142 |
Ziyan Wang, Keyong Fang, Guoqiang Wang, Xuewa Guan, Zhiqiang Pang, Yingqiao Guo, Yuze Yuan, Nan Ran, Yue Liu, Fang Wang. Protective effect of amygdalin on epithelial–mesenchymal transformation in experimental chronic obstructive pulmonary disease mice. Phytotherapy Research 2019; 33(3): 808 doi: 10.1002/ptr.6274
|
| 143 |
Ling Wang, Zongliang Jiang, Delun Huang, Jingyue Duan, Chang Huang, Shannon Sullivan, Kaneha Vali, Yexuan Yin, Ming Zhang, Jill Wegrzyn, Xiuchun ( Cindy) Tian, Young Tang. JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process. BMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-4507-2
|
| 144 |
Qidi Ying, Guanzhong Wu. Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update. Renal Failure 2017; 39(1): 474 doi: 10.1080/0886022X.2017.1313164
|
| 145 |
Minal Garg. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis. Expert Reviews in Molecular Medicine 2017; 19 doi: 10.1017/erm.2017.6
|
| 146 |
Xiaoying Ma, Jiajun Liu, Jiyu Li, Yueqi Li, Van Minh Le, Shaoyu Li, Xin Liang, Lingshuang Liu, Jianwen Liu. miR‐139‐5p reverses stemness maintenance and metastasis of colon cancer stem‐like cells by targeting E2‐2. Journal of Cellular Physiology 2019; 234(12): 22703 doi: 10.1002/jcp.28836
|
| 147 |
Dong Weng, Jian-xia Chen, Hao-hao Li, Feng Liu, Li-dan Zhou, Hai-peng Liu, Rui-juan Zheng, Yan Jiang, Zhong-hua Liu, Baoxue Ge. 2-aminopurine suppresses the TGF-β1-induced epithelial–mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis. Cell Death Discovery 2018; 4(1) doi: 10.1038/s41420-017-0016-3
|
| 148 |
Rui Cao, Lushun Yuan, Bo Ma, Gang Wang, Wei Qiu, Ye Tian. An EMT‐related gene signature for the prognosis of human bladder cancer. Journal of Cellular and Molecular Medicine 2020; 24(1): 605 doi: 10.1111/jcmm.14767
|
| 149 |
Ana Mitrović, Urša Pečar Fonović, Janko Kos. Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells. European Journal of Cell Biology 2017; 96(6): 622 doi: 10.1016/j.ejcb.2017.04.003
|
| 150 |
Amalia P. Vogiatzoglou, Syrago Spanou, Nikoleta Sachini, Elias Drakos, Christoforos Nikolaou, Takis Makatounakis, Androniki Kretsovali, Joseph Papamatheakis. Promyelocytic leukemia protein regulates angiogenesis and epithelial–mesenchymal transition to limit metastasis in MDA‐MB‐231 breast cancer cells. Molecular Oncology 2023; 17(10): 2090 doi: 10.1002/1878-0261.13501
|
| 151 |
Mousumi Tania, Md. Asaduzzaman Khan, Junjiang Fu. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumor Biology 2014; 35(8): 7335 doi: 10.1007/s13277-014-2163-y
|
| 152 |
A. Asgarova, K. Asgarov, Y. Godet, P. Peixoto, A. Nadaradjane, M. Boyer-Guittaut, J. Galaine, D. Guenat, V. Mougey, J. Perrard, J. R. Pallandre, A. Bouard, J. Balland, C. Tirole, O. Adotevi, E. Hendrick, M. Herfs, P. F. Cartron, C. Borg, E. Hervouet. PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma. OncoImmunology 2018; 7(5): e1423170 doi: 10.1080/2162402X.2017.1423170
|
| 153 |
Marzia Vasarri, Emanuela Barletta, Donatella Degl’Innocenti. Marine Migrastatics: A Comprehensive 2022 Update. Marine Drugs 2022; 20(5): 273 doi: 10.3390/md20050273
|
| 154 |
Chang-Peng Li, Mu-Yan Cai, Li-Juan Jiang, Shi-Juan Mai, Jie-Wei Chen, Feng-Wei Wang, Yi-Ji Liao, Wen-Hui Chen, Xiao-Han Jin, Xiao-Qing Pei, Xin-Yuan Guan, Mu-Sheng Zeng, Dan Xie. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. Carcinogenesis 2016; 37(6): 557 doi: 10.1093/carcin/bgw036
|
| 155 |
Sabine Hombach-Klonisch, Maryam Mehrpour, Shahla Shojaei, Craig Harlos, Marshall Pitz, Ahmed Hamai, Krzysztof Siemianowicz, Wirginia Likus, Emilia Wiechec, Brian D. Toyota, Reyhane Hoshyar, Amir Seyfoori, Zahra Sepehri, Sudharsana R. Ande, Forough Khadem, Mohsen Akbari, Adrienne M. Gorman, Afshin Samali, Thomas Klonisch, Saeid Ghavami. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response. Pharmacology & Therapeutics 2018; 184: 13 doi: 10.1016/j.pharmthera.2017.10.017
|
| 156 |
Tariq Alqahtani, Vishnu Kumarasamy, Sahar Saleh Alghamdi, Rasha Saad Suliman, Khalid Bin Saleh, Mohammed A. Alrashed, Mohammed Aldhaeefi, Daekyu Sun. Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes. Cancers 2023; 15(7): 2163 doi: 10.3390/cancers15072163
|
| 157 |
Mir Mohd Faheem, Archana Katoch, Anindya Goswami. Tumor Suppressor Par-4. 2021; : 1 doi: 10.1007/978-3-030-80558-6_1
|
| 158 |
Katerina Grafanaki, Ioannis Grammatikakis, Arin Ghosh, Vishaka Gopalan, Gulden Olgun, Huaitian Liu, George C. Kyriakopoulos, Ilias Skeparnias, Sophia Georgiou, Constantinos Stathopoulos, Sridhar Hannenhalli, Glenn Merlino, Kerrie L. Marie, Chi-Ping Day. Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response. Pharmacology & Therapeutics 2023; 248: 108466 doi: 10.1016/j.pharmthera.2023.108466
|